Home Top Movers Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (HSTO) stock plunged during pre-market trading. What’s driving it low?

Histogen Inc. (NASDAQ: HSTO) stock gained by 16.16% at last close whereas the HSTO stock price declines by 2.73% in the pre-market trading. Histogen Inc. is a clinical-stage pharmaceuticals business focusing on creating potentially first-in-class restorative medicines that activate the body’s inherent repair and maintenance processes.

>> 7 Top Picks for the Post-Pandemic Economy << 

Current Update

HSTO released the top-line findings of HSTO’s Phase 1 trial of emricasan in mild symptomatic COVID-19 patients to assess safety, tolerability, and preliminary effectiveness. In comparison to the placebo, emricasan was shown to be safe and well tolerated over the 14-day dosing period and at the 45-day follow-up, with no major side events reported. At day 7, patients who finished emricasan treatment experienced a full remission of the symptoms most often associated with moderate COVID-19, such as cough, headache, and fatigue, which lasted until day 45. COVID-19 symptom remission was not observed in patients in the placebo group who completed the study until day 45.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

In addition, a number of critical observations on clinical outcomes, laboratory results, and drug target-related biomarkers were made. Individuals in the active medication group had positive changes in their caspase biomarkers, but patients in the placebo group remained to exhibit COVID-19-related symptoms and laboratory results.

Official Statements

Raavi Gupta, M.D. Associate Professor and the Principal Investigator at SUNY Downstate Health Sciences University said that the safety and potential therapeutic value of emricasan in the treatment of mild symptomatic individuals are highlighted by findings from a Phase 1 trial conducted in an outpatient environment.

Richard W. Pascoe, Histogen’s President, and Chief Executive Officer commented,

These excellent findings support emricasan’s substantial clinical safety record and clearly imply that it might be developed as a therapeutic therapy for mild to moderate COVID-19 and other viral inflammatory disorders. HSTO is excited to collaborate with their Amerimmune colleagues as they define a strategic route for emricasan’s clinical development choices and partnering prospects.

>> 7 Top Picks for the Post-Pandemic Economy << 

Dr. Oral Alpan, M.D. Chief Executive Officer of Amerimmune LLC commented,

The results revealed that the emricasan group had full and early remission of COVID-19-related symptoms, whereas the placebo group had symptoms that persisted. But, it offered significant insight into the illness process, which will be crucial in the development of COVID-19 treatment alternatives. They’re looking forward to collaborating with Histogen to bring Amerimmune’s skills to the emricasan research program as an example of how physician-owned diagnostic laboratories may be the source of medical discoveries and actively engage in the development of innovative treatments.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Energous Corporation Inc. (WATT) stock declines during after-market. Here’s to know why?

Energous Corporation Inc. (WATT) stock gained by 7.05% at last close whereas the WATT stock price plunged by 7.82% in the after-hours trading session....

AMAZON Inc. (AMZN) stock fell during after-market. Here’s the update

Amazon Inc. (NASDAQ: AMZN) stock plunged by 0.84% at last close however moving ahead the AMZAN share price also declines by 7.44% in the...

Cocrystal Pharma Inc. (COCP) stock soars during current market. Here’s what you should know

Cocrystal Pharma Inc. (NASDAQ: COCP) stock gains by 17.44% in the current market trading session. Cocrystal Pharma, Inc. is a clinical-stage biotechnology firm focused...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

ImmunoPrecise Inc. (IPA) stock fell during pre-market. What’s the update?

ImmunoPrecise Inc. (NASDAQ: IPA) stock declined by 8.39% at last close while the IPA stock-price plunge by 4.87% in pre-market as well. ImmunoPrecise is...

ECMOHO Ltd. (MOHO) stock plunged during pre-market. Let’s see what’s happening?

ECMOHO Ltd. (NASDAQ: MOHO) stock gained by 7.05% at last close, while during pre-market MOHO stock has been seen declining by 7.75%. In China's...

Synthetic Biologics Inc. (SYN) stock plunged during pre-market. Here’s what you should know?

Synthetic Biologics Inc. (NASDAQ: SYN) stock gained by 8.09% at last close whereas the SYN stock price declines by 0.54% in the pre-market trading....

Related News

Here is why OPKO Health Inc. (OPK) stock plunged on Thursday?

OPKO Health Inc. (OPK) shares lost 7.24% in after-hours on Thursday, July 29, 2021, and closed the daily trading at $3.46 per share. in...

Why Electrameccanica Vehicles Corp. (SOLO) stock performed well on Wednesday?

Electrameccanica Vehicles Corp. (SOLO) shares gained 5.71% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $3.70 per share. in...

Encore Wire Corporation Inc. (WIRE) stock surges during current market. Here’s to know why?

Encore Wire Corporation Inc. (NASDAQ: WIRE) stock gained by 11.10% in the current market trading session. Encore Wire Corporation is a prominent manufacturer of...

Why Futu Holdings Limited (FUTU) stock is surging in pre-market on Wednesday?

Futu Holdings Limited (FUTU) shares surged 7.56% in pre-market on Wednesday, July 28, 2021, as of this writing. Yesterday in the after-hours session, FUTU's...

Mattel Inc. (MAT) stock surged during pre-market trading, post financial results announcement

Mattel Inc. (NASDAQ: MAT) stock declined by 1.2% at the last close whereas the MAT stock price rises by 5.26% in the pre-market trading...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam